We are delighted to announce that the TransBioLine Newsletter Year 2 is online!
This Newsletter summarizes the highlights of the scientific progress and the consortium activities during the second year of the project.

Don’t want to miss a thing about TransBioLine?

Subscribe to our newsletter now!

The TransBioLine project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA